Skip to main content

Page last checked

Goal

Peptides for immune support

Sellers offer three peptides on this site for immune support. The one with the largest trial behind it did not beat placebo.

Source: Based on 3 compound guides · checked 2026-08-13

This category is unusual on this site because the evidence is not thin. Thymosin alpha-1 is an approved medicine in several countries and carries a trial record running to thousands of patients. The problem is what those trials were about.

They studied acutely unwell hospital patients — hepatitis B, liver failure, sepsis, melanoma — not healthy adults wanting resilience. Each row gives the practice, then what the trials covered.

At a glance

Compounds covered

3

With published human dosing

2 of 3

Approved or being tested for this

1

No human evidence for this goal

1

Three compounds, and who was enrolled

Read the right column for how ill the participants were. Every trial here enrolled hospital patients, which is not who buys these for immune support.

◆ 3 compounds coveredsources shown in each row
Compounds people take for this purpose, why they use them, what human research has measured, and where the evidence comes from.
CompoundWhat people take it forWhat research showsEvidence
Thymosin alpha-1Sold for immune support: long COVID, chronic infection, and general resilience in healthy adults.Approved outside the U.S.Under the name thymalfasin it is approved in several countries, mainly for chronic hepatitis B, where a 98-patient trial gave 1.6 mg twice a week for 26 or 52 weeks. Its largest trial gave 1.6 mg every 12 hours to 1,106 people with sepsis. By day 28, 23.4% had died on the drug against 24.1% on placebo.limited human dataDose from a human trial · no FDA label
LL-37Sold for stubborn infections, for biofilms, and for gut complaints.Measured in a human studyIt has reached people twice in registered work: injected into melanoma deposits at 250 to 500 mcg, and applied to venous leg ulcers. Neither study tested an infection. FDA cited animal findings of harm to male reproduction, and of tumor-promoting activity in some tissues.limited human dataDose from a human trial · no FDA label
KPVSold for gut inflammation and for inflamed skin, as the calming fragment of a larger hormone.Reported use onlyIn mice given colitis chemically, and in colon cells in a dish, it quietens inflammatory signaling without the pigment effect of the parent hormone. FDA states it has found no data on any person receiving it, by any route.no human dose shown to workNo human dose published

1 is approved for this purpose outside the United States, but not by FDA. 1 rests on a human study that measured something in this goal. 1 rests on reported use alone, with no study behind it.

A large trial that answers the question is worth more than a small one that flatters it

The sepsis trial is the most valuable single result in this category. It enrolled 1,106 people and ran double-blind against placebo. By day 28 it reported 23.4% mortality on the drug against 24.1% on placebo. That is a real answer to a hard question, and the answer is no.

A seller will not quote it, because a negative phase 3 is the opposite of a testimonial. A reader weighing whether to spend money on this compound should want it most of all. It is the only study here big enough to settle anything.

The approval is also real and it is worth reading precisely. An approval granted elsewhere carries that jurisdiction’s review standard and its permitted claims, not America’s. There is a practical gap too. The trials dissolve 1.6 mg of powder in 1 mL and inject that. Research vials under this name hold 5 mg or 10 mg.

Nobody has studied a healthy adult

Every trial on these three records enrolled people who were already ill — hepatitis B, acute-on-chronic liver failure, sepsis, metastatic melanoma, venous leg ulcers. Immune support in a well person is not an endpoint any of them measured.

That is a different statement from the compound not working. It is that nobody has asked the question people buy it to answer. The trials that exist tell you what happens when a very sick person receives it, which is useful and is not the same thing.

Where to go next

Which purposes have evidence behind them

4 pairings have an FDA-approved product, 2 have an approval outside the U.S., and 6 are being tested in trials.

What Thymosin alpha-1 is, how it is used, and what has been studied

Thymosin alpha-1 is a thymic immunomodulatory peptide (approved outside the united states).

What LL-37 is, how it is used, and what has been studied

LL-37 is a human cathelicidin antimicrobial peptide (research compound).

How KPV differs from the rest of its class

No published human dosing schedule was found for KPV.

Where the testosterone evidence stops

Compare all 4 compounds associated with testosterone, with a source for every supported claim.

Every compound sold for skin

3 compounds are sold or prescribed for skin; the comparison shows what has actually been studied.

The sexual function table, basis by basis

Compare why people use each compound with what human studies have actually measured for sexual function.

The anxiety and depression table, basis by basis

Compare why people use each compound with what human studies have actually measured for anxiety and depression.

Every purpose covered this way is listed on the index of goals people buy peptides for.

9primary sources, each with the day we read it — open the documents used on this page